Although the mechanism by which IL-6 is favorable during exercise is known, it would be interesting to know in depth the appropriate exercise time and intensity that enables improvements in the concentration of systemic cytokines, which, in turn, allows myostatin to be blocked at an appropriate intensity for the patient with RA. The gene discussed is IL6; the disease is rheumatoid arthritis.